High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
About this item
Full title
Author / Creator
Wildes, T M , Finney, J D , Fiala, M , Gao, F , Vij, R , Stockerl-Goldstein, K , Carson, K R , Mikhael, J and Colditz, G
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Randomized trials showing that high-dose therapy with autologous stem cell transplant (ASCT) improved the overall survival (OS) in multiple myeloma (MM) excluded patients over age 65. To compare the outcomes of older adults with MM who underwent ASCT with non-transplant strategies, we identified 146 patients aged 65–77 with newly diagnosed MM seen...
Alternative Titles
Full title
High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526374
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4526374
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2015.106
